A Agilent Technologies Inc.

Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers

(NYSE: A) today announced the selection of Distinguished Professors Michel Barsoum and Yury Gogotsi at and Professor Ananda Amarasekara at as recipients of an Agilent Solutions Innovation Research Award (SIRA). The three honorees will receive separate awards for their research into materials to advance energy storage technology.

Environmental issues related to decades of fossil fuel use have sharply highlighted the need for more efficient and durable batteries. Creating global energy resources that are both renewable and sustainable presents a significant technical challenge: developing new materials to improve the performance, longevity, and recyclability of commercial energy storage solutions.

Professors and are recognized for their efforts to develop nanomaterials for battery/electrochemical energy storage applications, including the development and study of MXenes – a new class of 2D materials made from transition metals – which they co-discovered in 2011. Professor Barsoum’s award includes a one-year loan of an Agilent 8900 ICP-QQQ system; Professor Gogotsi’s award consists of a one-year loan of an Agilent 5900 ICP-OES system.

Professor is recognized for his research into renewable electrical energy storage technologies and sustainable biofuels – specifically, developing a new energy-efficient and inexpensive method for recovering valuable metals from spent Li-ion batteries. Professor Amarasekara’s award consists of a one-year loan of an Agilent 7900 ICP-MS system.

Keith Bratchford, vice president and general manager of Agilent's Atomic Spectroscopy Division commented of the significance of the awards: “Agilent is proud to acknowledge the groundbreaking work of Professors Michel Barsoum, Yury Gogotsi, and Ananda Amarasekara. In a world seeking sustainable solutions and better energy storage, advanced materials and battery research hold immense importance; it is the catalyst for innovations that will reshape industries and drive technological advancements. By delving into advanced materials and battery technologies, we lay the groundwork for a more sustainable and resilient future. Agilent is proud to be a part of this transformative journey, with our atomic spectroscopy products playing a pivotal role in enabling and advancing crucial research in these areas.”

Professor Barsoum stated: “We are excited about this award. The Agilent 8900 ICP-QQQ system is a critical piece of equipment we now need to continue and enhance our research on advanced energy storage technology.”

Professor Gogotsi added: “The Agilent ICP optical emission spectrometer will allow us to quickly analyze trace elements in water. Its availability will facilitate the development of MXene membranes for water desalination and purification, as well as energy storage and harvesting. ICP metals analysis will also allow us to control the removal of lithium and other ions from MXenes when we wash and delaminate them, thus improving the purity of new 2D materials that we discover and develop in our lab.”

Professor Amarasekara stated: “We are encouraged by this award and continued collaboration with Agilent. The loaned instrument will be put to good use in our Li-ion battery recycling project as well as in environmental science research programs. The experience gained using this ICP-MS will be useful in developing our future research plans and departmental analytical instrument inventory.”

Agilent established the initiative in 2023 to stimulate innovative and impactful use of its products to help solve pressing scientific problems in academia. These awards underscore Agilent’s commitment to facilitating university research and enhancing awareness of and access to its portfolio of analytical solutions.

About Agilent Technologies

(NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on and .

EN
29/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approva...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ , a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise and reliable cell analysis solutions, Agilent assisted Autolus in achieving the high standards required for FDA approval. Dr. Xiaobo Wang, Vice President and General Manager of the Cell Functio...

 PRESS RELEASE

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 (NYSE: A) is excited to announce its participation at the upcoming , which will be held March 22-27, 2025, in Boston. At the conference, Agilent will highlight innovative digital pathology solutions designed to enhance diagnostic accuracy and efficiency. In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzi...

 PRESS RELEASE

Agilent Research Catalyst Award Presented to Columbia University for P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that has received an Agilent Research Catalyst (ARC) Award on behalf of , an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of Cellular Immunotherapy Laboratory at Columbia University Irving Medical Center. He is also an Assistant Professor of Medicine at Columbia University Medical Center, a principal investigator at the Columbia Center for Translational Immunology (CCTI), and a member of the Herbert Irv...

 PRESS RELEASE

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Com...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced its kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications launched in Europe for PD-L1 IHC 28-8 pharmDx to nine. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Lung cancer and malignant melanoma are major healthcare concerns worldwide, with lung cancer accountin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch